Nurse Practitioner, Family · Colorado Springs, CO
NPI
1194201608
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2502 E Pikes Peak Ave Ste 100
Colorado Springs, CO, 80909
Phone (719) 314-2327
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
11,522 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tamara J Stull prescribed most often to Medicare patients was Rosuvastatin Calcium, with 768 prescriptions and refills. In total Tamara J Stull wrote 11,522 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 768 | 768 | 74 | $60K |
| Levothyroxine Sodium Generic | 499 | 499 | 51 | $6,383 |
| Pantoprazole Sodium Generic | 458 | 458 | 49 | $35K |
| Gabapentin Generic | 367 | 367 | 35 | $10K |
| Potassium Chloride Generic | 342 | 342 | 39 | $5,414 |
| Lisinopril Generic | 295 | 295 | 32 | $4,417 |
| Furosemide Generic | 292 | 292 | 34 | $2,395 |
| Trazodone Hcl Generic | 285 | 285 | 36 | $4,758 |
| Amlodipine Besylate Generic | 268 | 268 | 30 | $6,108 |
| Losartan Potassium Generic | 217 | 217 | 20 | $5,479 |
| Eliquis Apixaban | 203 | 203 | 23 | $117K |
| Famotidine Generic | 182 | 183 | 31 | $6,142 |
| Escitalopram Oxalate Generic | 176 | 176 | 21 | $7,543 |
| Metoprolol Succinate Generic | 167 | 167 | 21 | $2,673 |
| Carvedilol Generic | 162 | 162 | 16 | $6,656 |
Brand drugs: 2,310 claims; generic drugs: 9,156 claims; opioid claims: 191.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tamara J Stull were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.